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Abstract
High tumor interstitial fluid pressure (TIFP) is a char-
acteristic of most solid tumors. TIFP may hamper ade-
quate uptake of macromolecular therapeutics in tumor
tissue. In addition, TIFP generates mechanical forces
affecting the tumor cortex, which might influence the
growth parameters of tumor cells. This seems likely as,
in other tissues (namely, blood vessels or the skin),
mechanical stretch is known to trigger proliferation.
Therefore, we hypothesize that TIFP-induced stretch
modulates proliferation-associated parameters. Solid
epithelial tumors (A431 and A549) were grown in Naval
Medical Research Institute nude mice, generating a
TIFP of about 10 mm Hg (A431) or 5 mm Hg (A549).
Tumor drainage of the central cystic area led to a
rapid decline of TIFP, together with visible relaxation of
the tumor cortex. It was found by sodium dodecyl
sulfate polyacrylamide gel electrophoresis and West-
ern blot analysis that TIFP lowering yields a decreased
phosphorylation of proliferation-associated p44/42
mitogen-activated protein kinase and tumor relaxa-
tion. In confirmation, immunohistochemical staining
showed a decrease of tumor-associated proliferation
marker Ki-67 after TIFP lowering. These data suggest
that the mechanical stretch induced by TIFP is a posi-
tive modulator of tumor proliferation.
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Introduction
It is a common observation that interstitial fluid pressure is
elevated in both human and experimental solid tumors
compared to normal tissues [1–3]. Enhanced tumor inter-
stitial fluid pressure (TIFP) is mainly the result of a richly
developed and highly permeable vascular network, com-
bined with facilitated transendothelial fluid transfer [4,5].
Furthermore, the lack of a functional lymphatic system and
the abnormal vasculature in the tumor area give rise to
hypertension [6–8]. Clinically, a high TIFP is marked by a re-
duced delivery and uptake of anticancer drugs or macro-
molecules and, hence, lack of therapeutic effects [9].
In addition, vascular and interstitial fluid pressure may be
considered to result in permanent stretching stimulation to
the tumor cortex. As mechanical stretch has been identified
as a trigger factor supporting cell proliferation in other tissues, it
seems likely that the TIFP also triggers tumor cell proliferation
[10–14]. This assumption is backed by findings demonstrating
the activation of mitogen-activated protein kinase (MAPK) in
response to mechanical stimuli in various cell lines, suggesting
a ubiquitous reaction to mechanical stress [15–17]. In particu-
lar, mechanical stretch displayed a strong activation of p44/42
MAPK—a key regulator in proliferation-associated signaling—
in epithelial cells [12,13,18]. There is a huge body of evidence
indicating that surface receptors of the integrin family convey
the phosphorylation and activation of MAPKs through EGFR
transactivation [12,19–21].
The proliferative nature of mechanical stretch is further
evidenced by studies regarding cell count and the expression
of the nuclear antigen Ki-67 [22,23]. Ki-67 is expressed in all
phases of the cell cycle, except in the G0 phase, and serves as
a gold standard in tumor diagnosis [24,25]. In various hyper-
proliferative diseases, the expression of Ki-67 and the activation
of p44/42 MAPK were found to be closely correlated [26,27].
In the present study, the mechanical aspect of TIFP in solid
tumors during tumor cell proliferation was investigated for the
first time. We hypothesized that, by lowering TIFP, mechanical
relaxation of the tumor cortex controls proliferation-relevant ef-
fectors such as p44/42 MAPK and Ki-67.
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Animals and Experimental Tumors
Female Naval Medical Research Institute (NMRI) nude
mice (5–6 weeks, 20–24 g; Janvier Elevage, Le Genest
St. Isle, France) were subcutaneously implanted with 2-mm3
tissue fragments of A431 epidermoid vulva carcinoma or
A549 lung carcinoma. Both epithelial tumors featured a cystic
nature with viable tissue only in the periphery and a central
area filled with vascular fluid and necrotic cells.
Mice were kept under specific pathogen-free conditions.
Sterilized food and tap water were given ad libitum. Animals
were anesthesized with ketamine/xylazine (100/10 mg/kg,
i.p.; Pharmacia, Erlangen, Germany/BayerVital, Leverkusen,
Germany). During anesthesia administration, mice were
placed on a regulated heating pad to keep the body temper-
ature at 38 to 39jC. At the end of the experiments, anesthe-
sized mice were sacrificed by cervical dislocation.
Tumor size was measured with calipers every 3 days,
starting 7 days after implantation of tumor fragments, and
tumor volume was calculated as described previously [28].
TIFP was evaluated using the ‘‘wick-in-needle’’ technique in
the central cystic area and was related to tumor volume [29].
Fluid communication between the needle and the tumor tis-
sue was tested by compressing and decompressing the
tubing, and data were accepted only if the recorded pressure
returned rapidly to the value prior to tube compression. TIFP
measurement began at a tumor volume of 500 mm3. After
tumor puncture using a hollow needle (15 G), the TIFP
equaled control measurements in the subcutis (0 to 1 mm
Hg). To detect changes in MAPK phosphorylation, tumors
were excised 5 minutes, 10 minutes, 30 minutes, 60 minutes,
and 6 hours after puncture. Changes in Ki-67 expression
were evaluated in tumor specimens excised after 24 hours.
To avoid reinflation of the tumor, a redon-mini drain system
(pfm, Cologne, Germany) was applied. The suction bellow of
the redon-mini drain was fixed to a crane device (CMA Micro-
dialysis, Solna, Sweden) to allow free movement of mice.
All animal experiments were approved in accordance with
German animal welfare regulations.
Immunoblotting
For analysis of mechanically induced MAPK activation,
tumor tissue was homogenized in cell lysis buffer (Cell
Signaling Technology, Frankfurt/Main, Germany) using an
ultrathurax (IKA, Staufen, Germany). After sonication and
centrifugation, the protein concentration of the supernatant
was determined (DC Protein Assay Kit; BioRad, Munich,
Germany) and standardized using bovine serum albumin
(BSA). Equal protein amounts (10 mg) were mixed with 3
sodium dodecyl sulfate (SDS) sample buffer [187.5mMTris–
HCl (pH 6.8), 6% SDS, 30% glycerol (water-free), 150 mM
DTT, and 0.3% bromophenol blue–Na] and separated by
electrophoresis on 12% SDS–polyacrylamide gels. For im-
munoblotting, proteins were transferred to PVDF mem-
branes (Roth, Karlsruhe, Germany). The membranes were
placed in blocking buffer [Tris-buffered saline (pH 7.6), 0.1%
Tween-20, and 5% BSA] for at least 1 hour, followed by
overnight incubation with primary antibodies in blocking
buffer at 4jC. Phosphorylation of p44/42 was detected using
a phosphospecific antibody (Thr202/Tyr204; Cell Signaling
Technology). Detection of total p44/42 (Cell Signaling Tech-
nology) served as loading control. Bound primary anti-
bodies were detected with secondary antibodies coupled to
horseradish peroxidase (antirabbit; Cell Signaling Technol-
ogy) and visualized with LumiGlo detection system (Cell Sig-
naling Technology).
Immunohistochemical Staining
Tumors were fixed in 4% paraformaldehyde, dehydrated,
embedded in paraffin, and cut using a Leica RM2125 rotary
microtome (Leica Microsystems, Wetzlar, Germany). Before
staining, tumor slides were dried for 15 minutes at 65jC,
dewaxed in xylene, and rehydrated in graded alcohols,
followed by heat-induced epitope retrieval in 10 mM citrate
buffer (pH 6.0; DakoCytomation, Hamburg, Germany). After
cooling the specimen for 20 minutes, tissue slides were
washed [H2O2/methanol, 0.1% Triton–phosphate-buffered
saline (PBS), and 2% glycin–PBS] and incubated for 10 min-
utes with a protein-blocking agent (Immunotech, Marseilles,
France). Then the slides were incubated with anti–human
Ki-67 (clone MIB-1, 1:50; DakoCytomation) in PBS for 1 hour
at room temperature. After three washes in PBS, slides
were incubated with a biotinylated secondary antibody and
a streptavidin peroxidase reagent (Immunotech) for 45 min-
utes. Staining was performed using AEC peroxidase sub-
strate kit (Vector Laboratories, Burlingame, CA). Sections
were counterstained with Mayer’s hematoxylin (AppliChem,
Darmstadt, Germany). Control staining was performed in
the absence of primary or secondary antibody, respectively.
Photographs were taken by a Sony Cyber Shot 3.3 (Sony
Deutschland, Cologne, Germany) connected to a Zeiss Axi-
oskop (Zeiss, Oberkochen, Germany). Ki-67 index was cal-
culated as the number of positive nuclei per 1000 nuclei.
Approximately 1000 nuclei (890–1100) were counted in the
viable rim area of 14 tumor slides of both tumor entities
(7 control, 7 drained tumors). Quantitative analysis was
performed using CellExplorer 2000 Software (BioSciTec,
Frankfurt/Main, Germany).
Immunofluorescent staining against CD31 was per-
formed according to the manufacturer’s instructions in
acetone-fixed frozen tumor sections using purified anti–
mouse CD31-PE antibody (clone 390, 1:200; Acris Anti-
bodies, Hiddenhausen, Germany).
Results
NMRI nude mice were subcutaneously transplanted into
the left and right parts of the back with fragments of A431
or A549 tumors. The measurement of tumor volume was
started 7 days after tumor fragments had been implanted.
Volumetric growth rate differed significantly between both
tumor entities. A tumor volume of 2000 mm3 was reached
after 15 days in A431 tumors, and after 27 days in A549
tumors (Figure 1A). TIFP was evaluated every 3 days, start-
ing after tumors had reached a volume of approximately
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500 mm3. In A431 tumors, TIFP increased constantly with
increasing tumor volume. At a tumor volume of 2000 mm3,
the maximum TIFP averaged 10 mm Hg. In A549 tumors, a
more moderate increase in TIFP was measured with maxi-
mum values of 5 mm Hg (Figure 1B). As shown in Figure 1C,
TIFP was lowered to 1 to 0 mm Hg after tumor puncture.
Control measurements in the subcutis of the mice showed
also interstitial fluid pressure values of 1 mm Hg (data not
shown). After tumor puncture, TIFP recovered rapidly within
6 hours, reaching TIFP values in the range of the level prior
to puncture (Figure 1C).
Permanent mechanical stretching, as induced by in-
creased TIFP, was found to influence cell morphology. The
mechanical load of the inflated A431 tumor is displayed by
a smooth and even surface (Figure 2A(I )). Puncture of the
same tumor resulted in a dramatic reduction in TIFP with
tumor collapse (Figure 2A(II )). A549 tumors showed a
similar morphology (data not shown). In a section of an
untreated A431 tumor stained with hematoxylin and eosin,
three distinct areas are visible: the central necrotic core, the
small viable rim of proliferating tumor cells, and the surround-
ing tumor capsule (Figure 2B(I )). Tumor cells of the outer
tumor cortex displayed expanded morphology. In contrast to
the avascular necrotic tumor center, this tissue layer is highly
vascularized, vital, and proliferative (Figure 2B(II )) [30,31].
To characterize molecular signaling cascades driven by
TIFP lowering, phosphorylation of p44/42 MAPK was inves-
tigated. Tissue samples of tumors were excised at 5 min-
utes, 10 minutes, 30 minutes, 60 minutes, and 6 hours after
tumor puncture and were analyzed for phospho-p44/42 by
Western blot analysis. It was found that the reduction of
TIFP for 30 and 60 minutes by puncture reduced the phos-
phorylation of p44/42 MAPK in A431 and A549 tumors
(Figure 3A). Control tumors showed a significantly stronger
phosphorylation of p44/42. Tumors excised 5 or 10 minutes
after TIFP lowering showed no significant reduction in
Figure 1. Tumor volume and TIFP in A431 and A549 tumors in NMRI nude
mice. (A) Increase of tumor volume after implantation of small fragments
(2 mm3) of A431 or A549 tumors. The plots represent tumor volume versus
time. (B) Effect of increasing tumor volume on the TIFP. (C) Effect of tumor
puncture on the TIFP. Scatter plots show the TIFP of five individual animals
6 hours before, during, and 6 hours after tumor puncture. Plots in (A) and (B)
show the results of n = 10 (A431/A549). Plots in (C) show results of n = 5
(A431) (mean ± SE).
Figure 2. Effect of puncture on tumor morphology. (A) (I) Untreated A431
control tumor features a tightly inflated tumor cortex. (II) After puncture of the
central cystic region, the tumor collapsed, indicating loss of surface tension.
(B) Sections from untreated A431 tumors stained with hematoxylin and eosin
to highlight mechanically stretched tumor cells. (I) The central necrotic area
(white arrow) is surrounded by proliferating tumor tissues (black arrow) and
tumor capsule (blue arrow). Original magnification, 100. (II) Black arrows
indicate stretched cells in the proliferative and highly vascularized outer tumor
cortex. Original magnification, 320.
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p44/42 MAPK phosphorylation compared to untreated con-
trol tumors (data not shown). In addition, p44/42 MAPK phos-
phorylation of tumors excised 6 hours after tumor puncture
showed similar levels as untreated controls (Figure 3A). Data
are summarized in Figure 3B.
To test whether proliferation is regulated by TIFP reduc-
tion, the expression of Ki-67 was evaluated. To enable TIFP
lowering for up to 24 hours, a redon-mini drain was implanted
in one of the tumors, circumventing the recovery of TIFP for
this time period. After 24 hours, mice were sacrificed, and
tumors were fixed in paraformaldehyde and embedded in
paraffin. The proliferation rate of tumors was determined
by immunohistochemical staining against the tumor prolife-
ration marker Ki-67 in A431 and A549 tumors (Figure 4, A
and B). Tumor samples from both tumor entities, drained for
24 hours (Figure 4, A(I ) and B(I )), showed a reduced ex-
pression of human Ki-67 proteins in the proliferating tumor
cortex compared to untreated control tumors (Figure 4, A(II )
and B(II)). The specificity of Ki-67 antibody staining was con-
trolled by withdrawal of the first or secondary antibody, re-
spectively (Figure 4A(III/IV )). An overview of a Ki-67–stained
tumor tissue, generated from an untreated control tumor,
indicates that only cells from the viable rim were used for
Ki-67 index determination (Figure 4A(V )). The quantitative
analysis of Ki-67 expression data showed that Ki-67 expres-
sion dropped significantly in drained A431 and A549 tumors
compared to the untreated control tumors (Figure 4C).
Furthermore, it was tested whether the release of tumor
fluid during drainage might destroy vessels in tumor tissues.
Staining of drained and untreated tumors with fluorescent-
linked antibodies against anti–mouse CD31 (PECAM), a
well-known endothelial cell marker, indicated that the vessels
in both TIFP-reduced and control tumors are not destroyed
and show opened lumina (Figure 5) [32].
Figure 3. Reduction of TIFP decreased the phosphorylation of proliferation-associated p44/42 MAPK. (A) Time course of p44/42 phosphorylation in untreated
A431 and A549 control tumors and in TIFP-lowered tumors. (B) Quantitative analysis of p44/42 MAPK phosphorylation in TIFP-reduced and control tumors. The
values from TIFP-lowered tumors have been normalized to values of control tumors. Data are mean ± SE (*P < .001 vs untreated control tumors; **P < .01 vs
untreated control tumors) for five independent experiments.
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Discussion
TIFP is described as a physical parameter that hampers the
uptake of antitumor drugs into tumor tissue [9]. In this respect,
therapeutic approaches lowering TIFP provide improvement
of drug delivery [33–35]. Furthermore, enhanced TIFP and
compressive forces generated by proliferating tumor cells
may lead to a permanent mechanical stretching of the tumor
cortex [36]. Nevertheless, a direct compression of cortical
tumor cells seems to be unlikely in a hydrostatic system. The
present study is driven by the hypothesis that modulation
of mechanical load within the central cystic area by reduction
of TIFP triggers proliferation-relevant parameters.
In a first step, the TIFP in A431 and A549 tumors was
measured and related to tumor volume. Particularly, A431
tumors indicate a strong correlation between TIFP and tumor
volume. These results are in concert with previously pub-
lished data showing that TIFP increases with tumor volume
in other tumor species [37–39]. Interestingly, TIFP values of
A549 tumors showed only a moderate correlation with tumor
growth, indicating that both parameters are not necessar-
ily correlated [40]. Nevertheless, measured TIFP values in
A549 tumors were significantly elevated compared to that in
subcutaneous tissues. Therefore, it may be assumed that
interstitial fluid pressure and compressive forces are respon-
sible for the stretching stimulus. This assumption is backed
by immunohistochemical data from A431 tumors indicating
that cells of the tumor cortex follow the stretching force vector.
As reviewed by Baxter and Jain [42], most solid tumors are
at least in part permeable to fluid flow and do not provide
complete fluid retention. Thus, tumor fluid leakage leads to
TIFP decrease from the cystic core to the tumor cortex [1].
It is assumed that the drain of tumor fluid is due to TIFP-
induced outward convective flux and elevated hydraulic
tissue conductivity [41–43]. It is considered that the main-
tenance of an elevated TIFP originates from the lack of a
functional lymphatic system, abnormal vasculature in the
tumor area, and interstitial fibrosis [3]. By puncture of the
central cystic area, the tumor cortex instantly collapsed and
the TIFP was drastically lowered, giving evidence that the
TIFP is an important contributor to tumor tension.
It was found that TIFP reduction leads to an immediate
decline of p44/42 MAPK phosphorylation in both tumor cell
lines within 30 to 60 minutes. Tissue samples analyzed
Figure 4. 24-Hour TIFP lowering reduced Ki-67 expression. (A) Immunohis-
tochemical staining of Ki-67 in A431 tumor slides in response to reduced TIFP.
(I) Ki-67 expression in TIFP-reduced tumor tissue. (II) Ki-67 expression in un-
treated control tumors. (III/IV) control staining after withdrawal of the first or
secondary antibody. (V) Overview of a tissue slide of a control tumor stained
against Ki-67. Original magnification, 240 (I – IV) and 100 (V). (B) Immuno-
histochemical staining of Ki-67 in A549 tumor slides in response to lowered
TIFP. (I) Ki-67 expression in TIFP-lowered tumor tissue. (II) Ki-67 expression
in untreated control tumors. Original magnification, 240. (C) Summarized
graphical representation of Ki-67 expression. A significant reduction in Ki-67
expression is visible in TIFP-lowered A431 and A549 tumors. The results are
the mean ± SE of seven tumors (*P < .001 and **P < .05).
Figure 5. Reduced TIFP shows no effect on vessel architecture. Immuno-
histochemical staining of vessels using CD31-PE antibodies in A431 tumor
slides. (I) CD31 staining of drained tumors. (II) CD31 staining of control tumors.
Original magnification, 320.
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6 hours after tumor puncture show a recovered phosphory-
lation pattern of p44/42 MAPK, as seen in control tumors.
These data are in concert with our findings that the TIFP re-
covered quickly within 5 to 6 hours after a single puncture. To
study the effects of TIFP release for a longer time span, a
redon-mini drainage system was introduced. With this set-
up, a decrease of Ki-67 expression was demonstrated. The
complex changes within the tumor tissue caused by TIFP
withdrawal are responsible for measured effects. The con-
cept that TIFP-induced stretching stimulates tumor prolifera-
tion is supported by various studies showing that mechanical
stretch facilitates cell proliferation in vitro [10,12–14]. In vivo
situations, such as skin enlargement by application of skin
expanders or during pregnancy, corroborate the proliferative
quality of mechanical stretch [11].
Based on a xenograft tumor model using two different
epithelial tumor cell lines, our results suggest that the reduc-
tion of mechanical stretch by TIFP lowering reduces tumor
proliferation. Therefore, our in vivo data are in concert with
recently published results from Nathan et al. [44], who
showed that elevated physiological pressure enhanced the
proliferation of human osteosarcoma cells in vitro. Further-
more, it was shown bySalnikov et al. that PGE1-induced TIFP
reduction led to an enhanced drug delivery of 5-fluorouracil
and reduced tumor growth. In this model, tumor growth
reduction could be described by improved drug uptake and
by decreased mechanical tension applied by connective tis-
sue cells and extracellular matrix components [45]. This
work is particularly interesting as TIFP lowering is consid-
ered to promote mainly convection-driven transport [3]. It
was assumed that the uptake of small molecules, such as
most chemotherapeutic drugs, is driven by diffusion rather
than convection and is, therefore, independent of lowered
TIFP [41,42]. The work of Salnikov et al. [35] speaks against
this hypothesis as, in their model, the uptake of 5-fluorouracil
was enhanced by lowered TIFP. Recently, Heldin et al. [3]
reviewed the role of TIFP in drug delivery and hypothesized
that tissue changes promote the uptake of small molecules
by higher transvascular diffusion. Additionally, the authors
hypothesized that convection-driven transport maybe under-
estimated for small molecules [3].
Therapeutic strategies that simply enable TIFP lowering
pose the dilemma that withdrawal of mechanical stretch also
promotes interstitial fluid transport and therefore facilitates
the uptake of nutrients and growth factors into the tumor [3].
Paradoxically, better nutrition supply should imply increased
cell proliferation. However, it has to be mentioned that TIFP
lowering enhances drug delivery immediately [35,46]. In con-
trast, strategies that are based on the destruction of the
vasculature by antiangiogenic agents would impair the de-
livery of drugs to the tumor [47].
As a consequence, a combination of TIFP reduction and
simultaneous application of antitumor drugs seems favor-
able. This approach may offer a two-hit strategy that dimin-
ishes stretch-induced proliferation together with enhanced
drug supply. In conclusion, our data define TIFP as a trigger
factor of tumor proliferation with implications for future thera-
peutic strategies.
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